{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:19:06Z","timestamp":1767658746641,"version":"3.48.0"},"reference-count":140,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lung cancer is the leading cause of cancer deaths worldwide, claiming more lives than other age-related and screen-detectable cancers. Cigarette smoking remains the most important risk factor. However, despite common perceptions, risk is not related solely to cigarette smoking. Several vulnerable and special populations experience a disproportionate burden of lung cancer, often complicated by overlapping medical issues, diagnostic challenges, and treatment limitations. This review highlights four populations (people with HIV, persons who are immunocompromised, lung cancer in nonsmoking women, and individuals with interstitial lung disease [ILD]) who experience unique risks that impact early detection, diagnosis, and management of lung cancer. Three of these populations are frequently underrepresented in clinical trials, yet they may be at elevated risk due to chronic inflammation, immune dysregulation, or previous medical therapies. Individuals with HIV have a significantly increased incidence of lung cancer, often presenting at younger ages and with more advanced disease. Similarly, patients who are immunocompromised following organ or stem cell transplantation are at heightened risk due to prolonged immune dysfunction and prior exposures to toxic therapies. Individuals with ILD, especially idiopathic pulmonary fibrosis (IPF), have an increased risk of developing lung cancer, which is challenging to detect with imaging given architectural distortion and even more challenging to treat given limited pulmonary reserve. We also highlight women, as there has been a striking trend of rising incidence of lung cancer among women worldwide, particularly among those who have never smoked. The intersection of these risks with traditional lung cancer risk factors like tobacco smoking highlights a critical need for increased awareness, improved risk stratification, and adapted screening strategies that take these complexities into account. In this review, we explore the epidemiology, clinical presentation, and early detection and management challenges unique to each population, underscoring the necessity of precision approaches to support individualized care.<\/jats:p>","DOI":"10.1055\/a-2657-9494","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T23:05:13Z","timestamp":1754607913000},"page":"479-489","source":"Crossref","is-referenced-by-count":0,"title":["Lung Cancer in Special Populations"],"prefix":"10.1055","volume":"46","author":[{"given":"Matthew","family":"Triplette","sequence":"additional","affiliation":[{"name":"Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington"},{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington School of Medicine, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda C.","family":"Aldrich","sequence":"additional","affiliation":[{"name":"Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"01","key":"ref1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"R L Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"08","key":"ref2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/cncr.35128","article-title":"Lung cancer statistics, 2023","volume":"130","author":"T B Kratzer","year":"2024","journal-title":"Cancer"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/JTO.0b013e31818020eb","article-title":"The International Epidemiology of Lung Cancer: geographical distribution and secular trends","volume":"3","author":"D R Youlden","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/ije\/dyv175","article-title":"Impact of changing US cigarette smoking patterns on incident cancer: risks of 20 smoking-related cancers among the women and men of the NIH-AARP cohort","volume":"45","author":"N D Freedman","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/COH.0000000000000327","article-title":"Evolving epidemiology of HIV-associated malignancies","volume":"12","author":"M S Shiels","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/M17-2499","article-title":"Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030","volume":"168","author":"M S Shiels","year":"2018","journal-title":"Ann Intern Med"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000534464","article-title":"Lung cancer presents at a younger age and is less likely to be curable in people living with HIV","volume":"103","author":"R Bhikoo","year":"2024","journal-title":"Respiration"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1016\/S2214-109X(17)30170-5","article-title":"Tobacco use among people living with HIV: Analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries","volume":"5","author":"N D Mdege","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"07","key":"ref9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","article-title":"Cumulative incidence of cancer among persons with HIV in North America: A cohort study","volume":"163","author":"M J Silverberg","year":"2015","journal-title":"Ann Intern Med"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"e700","DOI":"10.1016\/S2352-3018(22)00219-3","article-title":"Trends and risk of lung cancer among people living with HIV in the USA: A population-based registry linkage study","volume":"9","author":"C B Haas","year":"2022","journal-title":"Lancet HIV"},{"issue":"07","key":"ref11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/0003-4819-153-7-201010050-00008","article-title":"Age at cancer diagnosis among persons with AIDS in the United States","volume":"153","author":"M S Shiels","year":"2010","journal-title":"Ann Intern Med"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"19925","DOI":"10.1038\/s41598-022-24291-6","article-title":"Estimates of prevalence, time-trend, and association of smoking in adults living with HIV, HBV, and HCV (NHANES 1999-2018)","volume":"12","author":"J Yang","year":"2022","journal-title":"Sci Rep"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys","volume":"162","author":"R Mdodo","year":"2015","journal-title":"Ann Intern Med"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/QAD.0000000000001721","article-title":"Cancer burden attributable to cigarette smoking among HIV-infected people in North America","volume":"32","author":"S F Altekruse","year":"2018","journal-title":"AIDS"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/jamainternmed.2017.4349","article-title":"Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States","volume":"177","author":"K P Reddy","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"e017049","DOI":"10.1136\/bmjgh-2024-017049","article-title":"The impact of tobacco smoking and smoking cessation on lung cancer and stroke incidence among people with HIV on antiretroviral therapy in South Africa: A simulation modeling study","volume":"9","author":"H D'Couto","year":"2024","journal-title":"BMJ Glob Health"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.chest.2017.04.154","article-title":"Mechanisms underlying HIV-associated noninfectious lung disease","volume":"152","author":"R M Presti","year":"2017","journal-title":"Chest"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/bjc.2011.558","article-title":"Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection","volume":"106","author":"G M Clifford","year":"2012","journal-title":"Br J Cancer"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"e735","DOI":"10.1093\/cid\/ciab087","article-title":"Immunodeficiency and cancer in 3.5 million people living with human immunodeficiency virus (HIV): The South African HIV Cancer Match Study","volume":"73","author":"Y Ruffieux","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jnci\/djac053","article-title":"CD4\/CD8 ratio and cancer risk among adults with HIV","volume":"114","author":"J L Castilho","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/S2352-3018(16)30215-6","article-title":"Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study","volume":"4","author":"K Sigel","year":"2017","journal-title":"Lancet HIV"},{"issue":"07","key":"ref22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/QAD.0000000000001434","article-title":"Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals","volume":"31","author":"J L Marcus","year":"2017","journal-title":"AIDS"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/QAI.0000000000000523","article-title":"Cancer risk and use of protease inhibitor or non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study","volume":"68","author":"M Bruyand","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cllc.2011.05.005","article-title":"Lung cancer in HIV infection","volume":"13","author":"D Mani","year":"2012","journal-title":"Clin Lung Cancer"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"13196","DOI":"10.1038\/s41598-022-17237-5","article-title":"Prevalence of HPV-DNA and E6 mRNA in lung cancer of HIV-infected patients","volume":"12","author":"G Sirera","year":"2022","journal-title":"Sci Rep"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/QAD.0000000000003144","article-title":"Molecular profiling of breast and lung cancer in women with HIV reveals high tumor mutational burden","volume":"36","author":"C Caro-Vegas","year":"2022","journal-title":"AIDS"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"D R Aberle","year":"2011","journal-title":"N Engl J Med"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"H J de Koning","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0000000000001818","article-title":"Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells\/\u03bcl","volume":"32","author":"C Y Kong","year":"2018","journal-title":"AIDS"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/QAD.0000000000000943","article-title":"Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers","volume":"30","author":"A Makinson","year":"2016","journal-title":"AIDS"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"e0260069","DOI":"10.1371\/journal.pone.0260069","article-title":"Implementation of a lung cancer screening initiative in HIV-infected subjects","volume":"16","author":"J D\u00edaz-\u00c1lvarez","year":"2021","journal-title":"PLoS ONE"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"102334","DOI":"10.1016\/j.pmedr.2023.102334","article-title":"Lung cancer screening adherence among people living with and without HIV: An analysis of an integrated health system in Florida, United States (2012-2021)","volume":"35","author":"J Y Islam","year":"2023","journal-title":"Prev Med Rep"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/10732748221103624","article-title":"Low rates of lung cancer screening referrals in patients with human immunodeficiency virus: A correlational study","volume":"29","author":"W Lopez","year":"2022","journal-title":"Cancer Control"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10900-020-00844-6","article-title":"Cancer incidence and cancer screening practices among a cohort of persons receiving HIV care in Washington, DC","volume":"46","author":"A B Spence","year":"2021","journal-title":"J Community Health"},{"issue":"03","key":"ref35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/hiv.12811","article-title":"Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohort","volume":"21","author":"A Makinson","year":"2020","journal-title":"HIV Med"},{"issue":"02","key":"ref36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/QAI.0000000000002930","article-title":"Optimal lung cancer screening criteria among persons living with HIV","volume":"90","author":"S A Sellers","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chest.2024.07.147","article-title":"The use of a tailored decision aid to improve understanding of lung cancer screening in people with HIV","volume":"167","author":"N R Murphy","year":"2025","journal-title":"Chest"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.qai.0000232260.95288.93","article-title":"Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care","volume":"43","author":"M V Brock","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/QAD.0b013e32835ad56e","article-title":"Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals","volume":"27","author":"G Suneja","year":"2013","journal-title":"AIDS"},{"issue":"15","key":"ref40","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.23.02366","article-title":"Cancer treatment disparities in people with HIV in the United States, 2001-2019","volume":"42","author":"J K McGee-Avila","year":"2024","journal-title":"J Clin Oncol"},{"issue":"21","key":"ref41","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States","volume":"33","author":"A E Coghill","year":"2015","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/j.cllc.2020.11.006","article-title":"Decreased overall survival in HIV-associated non-small-cell lung cancer","volume":"22","author":"K Hysell","year":"2021","journal-title":"Clin Lung Cancer"},{"issue":"08","key":"ref43","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/QAD.0000000000002200","article-title":"Short-term outcomes for lung cancer resection surgery in HIV infection","volume":"33","author":"K M Sigel","year":"2019","journal-title":"AIDS"},{"issue":"08","key":"ref44","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.6004\/jnccn.2018.7064","article-title":"Evolving paradigms in HIV malignancies: Review of ongoing clinical trials","volume":"16","author":"R A Bender Ignacio","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"06","key":"ref45","first-page":"CD011120","article-title":"Interventions for tobacco use cessation in people living with HIV and AIDS","volume":"2016","author":"E R Pool","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"ref46","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/cncr.34462","article-title":"Cancer risk associated with cytomegalovirus infection among solid organ transplant recipients in the United States","volume":"128","author":"J M Geris","year":"2022","journal-title":"Cancer"},{"issue":"56","key":"ref47","doi-asserted-by":"crossref","first-page":"96419","DOI":"10.18632\/oncotarget.21682","article-title":"The association between human papillomavirus infection and lung cancer: a system review and meta-analysis","volume":"8","author":"W M Xiong","year":"2017","journal-title":"Oncotarget"},{"issue":"02","key":"ref48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/pathogens11020132","article-title":"Epstein-Barr virus infection in lung cancer: Insights and perspectives","volume":"11","author":"J C Osorio","year":"2022","journal-title":"Pathogens"},{"issue":"04","key":"ref49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.amjmed.2018.11.005","article-title":"Effects of smoking on solid organ transplantation outcomes","volume":"132","author":"K H Anis","year":"2019","journal-title":"Am J Med"},{"issue":"07","key":"ref50","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.21037\/jtd.2018.07.16","article-title":"Smoking resumption after heart or lung transplantation: A systematic review and suggestions for screening and management","volume":"10","author":"P Hofmann","year":"2018","journal-title":"J Thorac Dis"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1097\/TP.0000000000003773","article-title":"Cancer screening in solid organ transplant recipients: A focus on screening liver, lung, and kidney recipients for cancers related to the transplanted organ","volume":"106","author":"A Dharia","year":"2022","journal-title":"Transplantation"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3816\/CLC.2010.n.032","article-title":"Computed tomography-guided percutaneous needle biopsy of indeterminate pulmonary pathology: Efficacy of obtaining a diagnostic sample in immunocompetent and immunocompromised patients","volume":"11","author":"N Kothary","year":"2010","journal-title":"Clin Lung Cancer"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1111\/ajt.15495","article-title":"Epidemiologic perspectives on immunosuppressed populations and the immunosurveillance and immunocontainment of cancer","volume":"19","author":"E A Engels","year":"2019","journal-title":"Am J Transplant"},{"issue":"17","key":"ref54","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"E A Engels","year":"2011","journal-title":"JAMA"},{"issue":"05","key":"ref55","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/ajt.15181","article-title":"Risk of lung cancer in lung transplant recipients in the United States","volume":"19","author":"M Triplette","year":"2019","journal-title":"Am J Transplant"},{"issue":"08","key":"ref56","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients: A systematic review","volume":"67","author":"A Gutierrez-Dalmau","year":"2007","journal-title":"Drugs"},{"issue":"07","key":"ref57","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/s41416-024-02597-8","article-title":"Tumorigenic role of tacrolimus through mTORC1\/C2 activation in post-transplant renal cell carcinomas","volume":"130","author":"D Moldvai","year":"2024","journal-title":"Br J Cancer"},{"issue":"10","key":"ref58","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1097\/TP.0000000000000715","article-title":"Lung cancer prognosis in elderly solid organ transplant recipients","volume":"99","author":"K Sigel","year":"2015","journal-title":"Transplantation"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.lungcan.2020.06.018","article-title":"Characteristics and outcomes of lung cancer in solid organ transplant recipients","volume":"146","author":"L N Chen","year":"2020","journal-title":"Lung Cancer"},{"issue":"05","key":"ref60","doi-asserted-by":"crossref","first-page":"103004","DOI":"10.1016\/j.esmoop.2024.103004","article-title":"Immune checkpoint blockers in solid organ transplant recipients and cancer: The INNOVATED cohort","volume":"9","author":"J Remon","year":"2024","journal-title":"ESMO Open"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2019.11.010","article-title":"Immune checkpoint blockade for non-small cell lung cancer: What is the role in the special populations?","volume":"125","author":"R Califano","year":"2020","journal-title":"Eur J Cancer"},{"issue":"09","key":"ref62","doi-asserted-by":"crossref","first-page":"917.e1","DOI":"10.1016\/j.jtct.2024.06.021","article-title":"Current trends and outcomes in cellular therapy activity in the United States, including prospective patient-reported outcomes data collection in the Center for International Blood and Marrow Transplant Research Registry","volume":"30","author":"R Cusatis","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"08","key":"ref63","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"A D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"ref64","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.bbmt.2014.07.009","article-title":"Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning","volume":"20","author":"O Ringd\u00e9n","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"02","key":"ref65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11864-018-0528-y","article-title":"Second malignancies after hematopoietic stem cell transplantation","volume":"19","author":"I Danylesko","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"10","key":"ref66","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bbmt.2009.06.005","article-title":"The effect of smoking on allogeneic transplant outcomes","volume":"15","author":"D I Marks","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"07","key":"ref67","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41409-022-01678-7","article-title":"Clinical impact of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation: A multicenter retrospective study","volume":"57","author":"T Ohashi","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"ref68","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation","volume":"336","author":"R E Curtis","year":"1997","journal-title":"N Engl J Med"},{"issue":"05","key":"ref69","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic hematopoietic cell transplantation","volume":"113","author":"J D Rizzo","year":"2009","journal-title":"Blood"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaoncol.2018.4934","article-title":"Evaluation of second solid cancers after hematopoietic stem cell transplantation in European patients","volume":"5","author":"A Tichelli","year":"2019","journal-title":"JAMA Oncol"},{"issue":"01","key":"ref71","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1182\/blood-2010-07-294629","article-title":"Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning","volume":"117","author":"N S Majhail","year":"2011","journal-title":"Blood"},{"issue":"05","key":"ref72","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bmt.2014.13","article-title":"Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study","volume":"49","author":"I A Bilmon","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"ref73","doi-asserted-by":"crossref","first-page":"e32357","DOI":"10.1016\/j.heliyon.2024.e32357","article-title":"Glucocorticoids in lung cancer: Navigating the balance between immunosuppression and therapeutic efficacy","volume":"10","author":"W Xu","year":"2024","journal-title":"Heliyon"},{"issue":"01","key":"ref74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/resp.12919","article-title":"Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review","volume":"22","author":"A J Raymakers","year":"2017","journal-title":"Respirology"},{"issue":"12","key":"ref75","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/1940-6207.CAPR-20-0161","article-title":"Long-term glucocorticoid use and cancer risk: A population-based cohort study in South Korea","volume":"13","author":"T K Oh","year":"2020","journal-title":"Cancer Prev Res (Phila)"},{"issue":"02","key":"ref76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neo.2020.12.006","article-title":"Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment","volume":"23","author":"K Gong","year":"2021","journal-title":"Neoplasia"},{"issue":"01","key":"ref77","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1038\/s41467-022-33719-6","article-title":"Phase I trial of the TNF-\u03b1 inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas","volume":"13","author":"P K Paik","year":"2022","journal-title":"Nat Commun"},{"issue":"06","key":"ref78","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/annrheumdis-2013-204851","article-title":"Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis","volume":"74","author":"L K Mercer","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"01","key":"ref79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13075-022-02868-w","article-title":"The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study","volume":"24","author":"B Choi","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"03","key":"ref80","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry","volume":"141","author":"P C Mayor","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fimmu.2016.00365","article-title":"Cancers related to immunodeficiencies: Update and perspectives","volume":"7","author":"E Mortaz","year":"2016","journal-title":"Front Immunol"},{"issue":"07","key":"ref82","doi-asserted-by":"crossref","first-page":"djw295","DOI":"10.1093\/jnci\/djw295","article-title":"Proportion of never-smoker non-small cell lung cancer patients at three diverse institutions","volume":"109","author":"L Pelosof","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"02","key":"ref83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41571-023-00844-0","article-title":"Lung cancer in patients who have never smoked - an emerging disease","volume":"21","author":"J LoPiccolo","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"ref84","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/M18-1250","article-title":"Smoking and lung cancer mortality in the United States from 2015 to 2065: A comparative modeling approach","volume":"169","author":"J Jeon","year":"2018","journal-title":"Ann Intern Med"},{"issue":"11","key":"ref85","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jtho.2021.06.015","article-title":"High-ambient air pollution exposure among never smokers versus ever smokers with lung cancer","volume":"16","author":"R Myers","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"01","key":"ref86","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"R L Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"05","key":"ref87","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1200\/JCO.2006.07.2983","article-title":"Lung cancer incidence in never smokers","volume":"25","author":"H A Wakelee","year":"2007","journal-title":"J Clin Oncol"},{"issue":"21","key":"ref88","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa1715907","article-title":"Higher lung cancer incidence in young women than young men in the United States","volume":"378","author":"A Jemal","year":"2018","journal-title":"N Engl J Med"},{"issue":"05","key":"ref89","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5732\/cjc.011.10106","article-title":"East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians","volume":"30","author":"W Zhou","year":"2011","journal-title":"Chin J Cancer"},{"issue":"09","key":"ref90","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ejca.2012.03.007","article-title":"Lung cancer in never smokers\u2013a review","volume":"48","author":"S Couraud","year":"2012","journal-title":"Eur J Cancer"},{"issue":"03","key":"ref91","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ijc.35188","article-title":"Lung cancer incidence rates in young women and men by state in the United States","volume":"156","author":"A Jemal","year":"2025","journal-title":"Int J Cancer"},{"issue":"10","key":"ref92","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer progress and priorities: Lung cancer","volume":"28","author":"M B Schabath","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"01","key":"ref93","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2014.08.001","article-title":"Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009","volume":"86","author":"K A Houston","year":"2014","journal-title":"Lung Cancer"},{"issue":"01","key":"ref94","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccm.2019.10.005","article-title":"Lung cancer in women: A modern epidemic","volume":"41","author":"C R MacRosty","year":"2020","journal-title":"Clin Chest Med"},{"issue":"06","key":"ref95","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1055\/s-0033-1358550","article-title":"Lung cancer in women: Differences in epidemiology, biology, histology, and treatment outcomes","volume":"34","author":"M P Rivera","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"issue":"08","key":"ref96","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jtho.2021.04.007","article-title":"Long-term prognosis of patients with resected adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung","volume":"16","author":"M Yotsukura","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"12","key":"ref97","doi-asserted-by":"crossref","first-page":"djv279","DOI":"10.1093\/jnci\/djv279","article-title":"Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types","volume":"107","author":"J N Sampson","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"03","key":"ref98","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1086\/423857","article-title":"A major lung cancer susceptibility locus maps to chromosome 6q23-25","volume":"75","author":"J E Bailey-Wilson","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"12","key":"ref99","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/ng.2456","article-title":"Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia","volume":"44","author":"Q Lan","year":"2012","journal-title":"Nat Genet"},{"issue":"08","key":"ref100","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jtho.2019.04.008","article-title":"Lung cancer risk in never-smokers of european descent is associated with genetic variation in the 5p15.33 TERT-CLPTM1Ll region","volume":"14","author":"R J Hung","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer current: Status, challenges and future prospects","volume":"9","author":"L Ma","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"ref102","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/annonc\/mdz227","article-title":"How liquid biopsies can change clinical practice in oncology","volume":"30","author":"G Siravegna","year":"2019","journal-title":"Ann Oncol"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung cancer","volume":"85","author":"J A Barta","year":"2019","journal-title":"Ann Glob Health"},{"issue":"06","key":"ref105","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/oncolo\/oyac035","article-title":"Targeted next-generation sequencing reveals exceptionally high rates of molecular driver mutations in never-smokers with lung adenocarcinoma","volume":"27","author":"P C Mack","year":"2022","journal-title":"Oncologist"},{"issue":"09","key":"ref106","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"A Leiter","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"07","key":"ref107","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.cllc.2022.06.007","article-title":"Evaluating real world mutational differences between Hispanics and Asians in NSCLC at a large academic institution in Los Angeles","volume":"23","author":"R Hsu","year":"2022","journal-title":"Clin Lung Cancer"},{"issue":"13","key":"ref108","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S1470-2045(13)70487-X","article-title":"The carcinogenicity of outdoor air pollution","volume":"14","author":"D Loomis","year":"2013","journal-title":"Lancet Oncol"},{"issue":"10","key":"ref109","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jtho.2023.05.024","article-title":"Air pollution and lung cancer: A review by International Association for the Study of Lung Cancer Early Detection and Screening Committee","volume":"18","author":"C D Berg","year":"2023","journal-title":"J Thorac Oncol"},{"key":"ref111","first-page":"460","article-title":"Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations","volume":"70","author":"M C Turner","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"05","key":"ref112","first-page":"405","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019","volume":"74","author":"F Islami","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"06","key":"ref113","first-page":"776","article-title":"Tuberculosis and lung cancer risk in nonsmoking women","volume":"125","author":"M W Hinds","year":"1982","journal-title":"Am Rev Respir Dis"},{"issue":"12","key":"ref114","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.3390\/cancers15123111","article-title":"Sex differences in lung cancer","volume":"15","author":"L May","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"06","key":"ref115","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.seminoncol.2009.10.004","article-title":"Estrogen receptor signaling in lung cancer","volume":"36","author":"J M Siegfried","year":"2009","journal-title":"Semin Oncol"},{"issue":"22","key":"ref116","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1002\/cncr.28326","article-title":"The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology","volume":"119","author":"P F Pinsky","year":"2013","journal-title":"Cancer"},{"issue":"06","key":"ref117","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1513\/AnnalsATS.202408-863OC","article-title":"Why women appear to have better outcomes when undergoing screening for lung cancer?","volume":"22","author":"G A Silvestri","year":"2025","journal-title":"Ann Am Thorac Soc"},{"issue":"02","key":"ref118","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2213-2600(23)00338-7","article-title":"Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study","volume":"12","author":"G C Chang","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"08","key":"ref119","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jtho.2024.05.001","article-title":"Screening low-risk individuals for lung cancer: The need may be present, but the evidence of benefit is not","volume":"19","author":"G A Silvestri","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"08","key":"ref120","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jtho.2024.06.007","article-title":"Shades of gray: Do never smokers benefit from lung cancer screening programs?","volume":"19","author":"G A Woodard","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"09","key":"ref121","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/JTO.0000000000000593","article-title":"Should never-smokers at increased risk for lung cancer be screened?","volume":"10","author":"K Ten Haaf","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"02","key":"ref122","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2213-2600(23)00378-8","article-title":"Lung cancer screening in never-smokers: A balancing act","volume":"12","author":"M EJ Callister","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"23","key":"ref123","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/cncr.35083","article-title":"The American Cancer Society National Lung Cancer Roundtable strategic plan: Lung cancer in women","volume":"130","author":"L M Backhus","year":"2024","journal-title":"Cancer"},{"issue":"02","key":"ref124","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.chest.2021.06.035","article-title":"Detection and early referral of patients with interstitial lung abnormalities: An expert survey initiative","volume":"161","author":"G M Hunninghake","year":"2022","journal-title":"Chest"},{"issue":"06","key":"ref125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","article-title":"Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"8","author":"GBD Chronic Respiratory Disease Collaborators","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"01","key":"ref126","doi-asserted-by":"crossref","first-page":"00630-2021","DOI":"10.1183\/23120541.00630-2021","article-title":"The prevalence and burden of interstitial lung diseases in the USA","volume":"8","author":"N Jeganathan","year":"2021","journal-title":"ERJ Open Res"},{"issue":"01","key":"ref127","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/oncolo\/oyac226","article-title":"Management of lung cancer in the patient with interstitial lung disease","volume":"28","author":"A J Frank","year":"2023","journal-title":"Oncologist"},{"issue":"19","key":"ref128","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"D J Lederer","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"ref129","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.rmed.2007.07.012","article-title":"The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK","volume":"101","author":"I Le Jeune","year":"2007","journal-title":"Respir Med"},{"issue":"02","key":"ref130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4143\/crt.2017.119","article-title":"Interstitial lung disease and lung cancer development: A 5-year nationwide population-based study","volume":"50","author":"W I Choi","year":"2018","journal-title":"Cancer Res Treat"},{"issue":"03","key":"ref131","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ccm.2004.04.004","article-title":"Occupational interstitial lung disease","volume":"25","author":"C S Glazer","year":"2004","journal-title":"Clin Chest Med"},{"issue":"01","key":"ref132","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/ajrccm.155.1.9001319","article-title":"Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis","volume":"155","author":"K B Baumgartner","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref133","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.13120816","article-title":"Interstitial lung abnormalities in a CT lung cancer screening population: Prevalence and progression rate","volume":"268","author":"G Y Jin","year":"2013","journal-title":"Radiology"},{"issue":"04","key":"ref134","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1164\/rccm.202401-0238SO","article-title":"Genetics and genomics of pulmonary fibrosis: Charting the molecular landscape and shaping precision medicine","volume":"210","author":"A Adegunsoye","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"08","key":"ref135","doi-asserted-by":"crossref","first-page":"e0202360","DOI":"10.1371\/journal.pone.0202360","article-title":"Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis","volume":"13","author":"A JafariNezhad","year":"2018","journal-title":"PLoS ONE"},{"issue":"02","key":"ref136","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1513\/AnnalsATS.202103-295OC","article-title":"Epidemiology of idiopathic pulmonary fibrosis among U.S. Veterans, 2010-2019","volume":"19","author":"B Kaul","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"165","key":"ref137","doi-asserted-by":"crossref","first-page":"220003","DOI":"10.1183\/16000617.0003-2022","article-title":"Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: Current perspectives","volume":"31","author":"V Cottin","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"03","key":"ref138","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chest.2024.03.044","article-title":"Multi-cancer and single-cancer early detection testing: Opportunities and challenges","volume":"166","author":"J A Barta","year":"2024","journal-title":"Chest"},{"issue":"04","key":"ref139","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1158\/1055-9965.EPI-22-0099","article-title":"Biomarker-based lung cancer screening eligibility: Implementation considerations","volume":"31","author":"R J Hung","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"01","key":"ref140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","article-title":"Liquid biopsies: the future of cancer early detection","volume":"21","author":"S Connal","year":"2023","journal-title":"J Transl Med"},{"issue":"11","key":"ref141","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/thorax-2022-219068","article-title":"Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease","volume":"77","author":"R J Hewitt","year":"2022","journal-title":"Thorax"},{"issue":"08","key":"ref142","doi-asserted-by":"crossref","first-page":"a039537","DOI":"10.1101\/cshperspect.a039537","article-title":"Application of radiomics and artificial intelligence for lung cancer precision medicine","volume":"11","author":"I Tunali","year":"2021","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2657-9494.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T23:37:43Z","timestamp":1767656263000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2657-9494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":140,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2026,1,5]]},"published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2657-9494","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"type":"print","value":"1069-3424"},{"type":"electronic","value":"1098-9048"}],"subject":[],"published":{"date-parts":[[2025,8,7]]}}}